# Phibro Animal Health Corporation (PAHC)

Source: https://www.quantisnow.com/company/PAHC
Generated: 2026-11-09T23:18:05.984Z

- Ticker: PAHC
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2014
- SEC CIK: 0001069899
- Website: pahc.com

## About

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.

## Latest PAHC news and filings

- 2026-11-04 21:31 UTC [SEC Form 8-K] [Phibro Animal Health Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/phibro-animal-health-corporation-filed-sec-form-8-k-results-of-6773164)
- 2026-11-04 21:22 UTC [Earnings] [Phibro Animal Health Corporation Reports First Quarter Results, Maintains Financial Guidance](https://www.quantisnow.com/insight/phibro-animal-health-corporation-reports-first-quarter-results-maintains-financial-6772960)
- 2026-11-04 21:16 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Phibro Animal Health Corporation](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-phibro-animal-health-corporation-6772852)
- 2026-11-03 21:15 UTC [SEC Form 8-K] [Phibro Animal Health Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/phibro-animal-health-corporation-filed-sec-form-8-k-other-events-6769858)
- 2026-11-03 21:10 UTC [Dividends] [Phibro Animal Health Corporation Declares Quarterly Dividend](https://www.quantisnow.com/insight/phibro-animal-health-corporation-declares-quarterly-dividend-6769653)
- 2026-10-28 20:30 UTC [Earnings Date] [Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results](https://www.quantisnow.com/insight/phibro-animal-health-corporation-to-host-webcast-and-conference-call-6761577)
- 2026-09-18 20:12 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Phibro Animal Health Corporation](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-phibro-animal-health-corporation-6720553)
- 2026-09-18 20:10 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Phibro Animal Health Corporation](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-phibro-animal-health-corporation-6720542)
- 2026-09-17 21:33 UTC [SEC Form 4] [Amendment: Chief Financial Officer David Glenn was granted 3,482 shares, increasing direct ownership by 7% to 54,959 units (SEC Form 4)](https://www.quantisnow.com/insight/amendment-chief-financial-officer-david-glenn-was-granted-3482-shares-6719659)
- 2026-09-17 21:32 UTC [SEC Form 4] [Amendment: Chief Operating Officer Miller Larry Lee was granted 3,726 shares, increasing direct ownership by 11% to 38,275 units (SEC Form 4)](https://www.quantisnow.com/insight/amendment-chief-operating-officer-miller-larry-lee-was-granted-3726-6719657)
- 2026-09-09 20:30 UTC [Conference Announcement] [Phibro Animal Health Corporation to Participate in Morgan Stanley Annual Global Healthcare Conference](https://www.quantisnow.com/insight/phibro-animal-health-corporation-to-participate-in-morgan-stanley-annual-6710166)
- 2026-08-26 20:30 UTC [SEC Form 8-K] [Phibro Animal Health Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/phibro-animal-health-corporation-filed-sec-form-8-k-results-of-6695766)
- 2026-08-26 20:20 UTC [Earnings Date] [Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance](https://www.quantisnow.com/insight/phibro-animal-health-corporation-reports-fourth-quarter-and-fiscal-year-6695709)
- 2026-08-26 20:14 UTC [SEC Form 10-K] [SEC Form 10-K filed by Phibro Animal Health Corporation](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-phibro-animal-health-corporation-6695665)
- 2026-08-19 20:30 UTC [Earnings Date] [Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2026 Results](https://www.quantisnow.com/insight/phibro-animal-health-corporation-to-host-webcast-and-conference-call-6688515)
- 2026-08-10 20:19 UTC [SEC Form 4] [VP Finance and Treasurer Rodriguez Patrick was granted 1,503 shares (SEC Form 4)](https://www.quantisnow.com/insight/vp-finance-and-treasurer-rodriguez-patrick-was-granted-1503-shares-6673871)
- 2026-08-10 20:18 UTC [SEC Form 4] [Chief Financial Officer David Glenn was granted 3,334 shares, increasing direct ownership by 6% to 54,811 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-david-glenn-was-granted-3334-shares-increasing-6673862)
- 2026-08-10 20:17 UTC [SEC Form 4] [Chief Operating Officer Miller Larry Lee was granted 3,522 shares, increasing direct ownership by 10% to 38,071 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-operating-officer-miller-larry-lee-was-granted-3522-shares-6673858)
- 2026-08-10 20:17 UTC [SEC Form 4] [Director Bendheim Jonathan was granted 2,716 shares, increasing direct ownership by 83% to 5,984 units (SEC Form 4)](https://www.quantisnow.com/insight/director-bendheim-jonathan-was-granted-2716-shares-increasing-direct-ownership-6673849)
- 2026-08-10 20:16 UTC [SEC Form 4] [Officer Weinstein Judith was granted 2,478 shares, increasing direct ownership by 83% to 5,453 units (SEC Form 4)](https://www.quantisnow.com/insight/officer-weinstein-judith-was-granted-2478-shares-increasing-direct-ownership-6673840)
- 2026-08-10 20:16 UTC [SEC Form 4] [Executive Chairman Bendheim Jack was granted 12,103 shares (SEC Form 4)](https://www.quantisnow.com/insight/executive-chairman-bendheim-jack-was-granted-12103-shares-sec-form-6673831)
- 2026-08-10 20:15 UTC [SEC Form 4] [President and CEO Bendheim Daniel M was granted 11,699 shares, increasing direct ownership by 336% to 15,177 units (SEC Form 4)](https://www.quantisnow.com/insight/president-and-ceo-bendheim-daniel-m-was-granted-11699-shares-6673816)
- 2026-08-10 20:15 UTC [SEC Form 4] [Officer Escudero Lisa Ann was granted 1,547 shares, increasing direct ownership by 82% to 3,434 units (SEC Form 4)](https://www.quantisnow.com/insight/officer-escudero-lisa-ann-was-granted-1547-shares-increasing-direct-6673805)
- 2026-08-07 00:12 UTC [SEC Form 4] [Executive Chairman Bendheim Jack disposed of $84,287 worth of shares (2,303 units at $36.60) (SEC Form 4) to cover withholding tax](https://www.quantisnow.com/insight/executive-chairman-bendheim-jack-disposed-of-84287-worth-of-shares-6670284)
- 2026-08-07 00:12 UTC [SEC Form 4] [Officer Escudero Lisa Ann disposed of $9,699 worth of shares (265 units at $36.60), decreasing direct ownership by 12% to 1,887 units (SEC Form 4) to satisfy withholding obligation](https://www.quantisnow.com/insight/officer-escudero-lisa-ann-disposed-of-9699-worth-of-shares-6670283)
- 2026-08-07 00:11 UTC [SEC Form 4] [Chief Operating Officer Miller Larry Lee disposed of $23,240 worth of shares (635 units at $36.60), decreasing direct ownership by 2% to 34,549 units (SEC Form 4) (tax liability)](https://www.quantisnow.com/insight/chief-operating-officer-miller-larry-lee-disposed-of-23240-worth-6670282)
- 2026-08-07 00:10 UTC [SEC Form 4] [Officer Weinstein Judith disposed of $17,275 worth of shares (472 units at $36.60), decreasing direct ownership by 14% to 2,975 units (SEC Form 4) to cover withholding tax](https://www.quantisnow.com/insight/officer-weinstein-judith-disposed-of-17275-worth-of-shares-472-6670281)
- 2026-08-07 00:10 UTC [SEC Form 4] [Chief Financial Officer David Glenn disposed of $30,743 worth of shares (840 units at $36.60), decreasing direct ownership by 2% to 51,477 units (SEC Form 4) to satisfy tax liability](https://www.quantisnow.com/insight/chief-financial-officer-david-glenn-disposed-of-30743-worth-of-6670280)
- 2026-08-07 00:10 UTC [SEC Form 4] [President and CEO Bendheim Daniel M disposed of $17,787 worth of shares (486 units at $36.60), decreasing direct ownership by 12% to 3,478 units (SEC Form 4) to satisfy tax liability](https://www.quantisnow.com/insight/president-and-ceo-bendheim-daniel-m-disposed-of-17787-worth-6670279)
- 2026-08-06 14:38 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Phibro Animal Health Corporation](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-phibro-animal-health-6668121)
- 2026-07-28 20:16 UTC [SEC Form 8-K] [Phibro Animal Health Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/phibro-animal-health-corporation-filed-sec-form-8-k-other-events-6651601)
- 2026-07-28 20:10 UTC [Dividends] [Phibro Animal Health Corporation Declares Quarterly Dividend](https://www.quantisnow.com/insight/phibro-animal-health-corporation-declares-quarterly-dividend-6651474)
- 2026-07-02 20:15 UTC [SEC Form 4] [SEC Form 4 filed by President and CEO Bendheim Daniel M](https://www.quantisnow.com/insight/sec-form-4-filed-by-president-and-ceo-bendheim-daniel-6625469)
- 2026-06-26 21:07 UTC [SEC Form 8-K] [Phibro Animal Health Corporation filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/phibro-animal-health-corporation-filed-sec-form-8-k-leadership-update-6617725)
- 2026-06-02 22:56 UTC [Insider Buy] [Director Corcoran E Thomas bought $317,700 worth of shares (10,000 units at $31.77), increasing direct ownership by 32% to 41,459 units (SEC Form 4)](https://www.quantisnow.com/insight/director-corcoran-e-thomas-bought-317700-worth-of-shares-10000-6585318)
- 2026-05-21 20:30 UTC [Conference Announcement] [Phibro Animal Health Corporation to Participate in Stifel Jaws & Paws Conference](https://www.quantisnow.com/insight/phibro-animal-health-corporation-to-participate-in-stifel-jaws-paws-6567693)
- 2026-05-15 00:48 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Phibro Animal Health Corporation](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-phibro-animal-health-6555267)
- 2026-05-07 23:34 UTC [SEC Form 4] [President and CEO Bendheim Jack sold $1,016,228 worth of shares (18,608 units at $54.61) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/president-and-ceo-bendheim-jack-sold-1016228-worth-of-shares-6540602)
- 2026-05-07 20:30 UTC [Conference Announcement] [Phibro Animal Health Corporation to Participate in Bank of America Securities Health Care Conference](https://www.quantisnow.com/insight/phibro-animal-health-corporation-to-participate-in-bank-of-america-6539742)
- 2026-05-06 20:39 UTC [SEC Form 8-K] [Phibro Animal Health Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/phibro-animal-health-corporation-filed-sec-form-8-k-results-of-6536101)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/PAHC
- Earnings history: https://www.quantisnow.com/earnings/PAHC
- Dividend history: https://www.quantisnow.com/dividends/PAHC
- Insider transactions: https://www.quantisnow.com/insiders/PAHC
- Options chain: https://www.quantisnow.com/options/PAHC
- SEC 8-K filings only: https://www.quantisnow.com/company/PAHC/8-k
- RSS and alerts for PAHC: https://www.quantisnow.com/docs/rss-feeds.md